High incidence of false-positive PET scans in patients with aggressive non-Hodgkin’s lymphoma treated with rituximab-containing regimens-Reference-Cited by-同舟云学术

High incidence of false-positive PET scans in patients with aggressive non-Hodgkin’s lymphoma treated with rituximab-containing regimens

Published:2009-02 Issue:2 Volume:20 Page:309-318
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Han H.S.,Escalón M.P.,Hsiao B.,Serafini A.,Lossos I.S.

Funder

United States Public Health Service—National Institutes of Health and the Dwoskin Family Foundation

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/2/309/393680/mdn629.pdf

Reference18 articles.

1. Revised response criteria for malignant lymphoma;Cheson;J Clin Oncol,2007

2. Lossos IS, Coleman F, Walker G, et al. Phase-2 study of R-MACLO-IVAM-T in newly diagnosed mantle cell lymphoma. Blood (ASH Annual Meeting Abstracts) 2007: 110.

3. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group;Cheson;J Clin Oncol,1999

4. Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma;Jerusalem;Haematologica,2000

5. 18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin's lymphoma-comparison with CT;Mikhaeel;Leuk Lymphoma,2000

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tailoring Specific Radiographic Response Criteria for Immunologic Therapies in Lymphoma;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

2. Значение ПЭТ, совмещенной с КТ, при диффузной В-крупноклеточной лимфоме: история вопроса, эволюция представлений и современные возможности метода (обзор литературы);Clinical Oncohematology;2024-02-20

3. Extramedullary Hematopoiesis in Treated Diffuse Large B-Cell Lymphoma of Bone;Clinical Nuclear Medicine;2023-10-25

4. 中期PET-CT在淋巴瘤一线治疗决策中的应用;Journal of Zhejiang University-SCIENCE B;2023-10

5. Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma;Journal of Internal Medicine;2023-06-08